Thyroid Eye Disease Market to Accelerate Substantially by 2034, Assesses DelveInsight | Key Companies Developing Therapies - Viridian Therapeutics, Roche, Immunovant, Amgen, Sling Therapeutics, ACELYRIN, Tourmaline Bio

According to DelveInsight's’ estimates, the thyroid eye disease market in 7MM is expected to show good positive growth, during the forecast period (2024–2034), mainly attributed to new product launches, robust pipeline of emerging therapies, rise in the geriatric population and government support for clinical development. According to DelveInsight's’ estimates, the thyroid eye disease market in 7MM is expected to show good positive growth, during the forecast period (2024–2034), mainly attributed to new product launches, robust pipeline of emerging therapies, rise in the geriatric population and government support for clinical development.

New York, USA, July 04, 2024 (GLOBE NEWSWIRE) -- DelveInsight’s report includes a comprehensive understanding of current treatment practices, thyroid eye disease emerging drugs, market share of individual therapies, and current and forecasted thyroid eye disease market size from 2020 to 2034, segmented into 7MM [the United States, the EU-4 (Italy, Spain, France, and Germany), the United Kingdom, and Japan]. Discover which therapies are expected to grab the thyroid eye disease market share @ Thyroid eye disease is an autoimmune condition often associated with hyperthyroidism, particularly Graves' disease. The immune system mistakenly attacks the muscles and fatty tissues around the eyes, leading to inflammation and swelling.

The primary cause of TED is the production of autoantibodies that target the thyroid-stimulating hormone receptor (TSHR), which is also expressed in the tissues around the eyes. This immune response results in characteristic symptoms such as bulging eyes (proptosis), eye redness, swelling, pain, double vision (diplopia), and, in severe cases, vision loss due to optic nerve compression. The diagnosis of thyroid eye disease involves a combination of clinical evaluation, imaging studies, and laboratory tests.

Ophthalmologists and endocrinologists often work together to assess the extent of eye involvement and thyroid function. Physical examination includes a detailed assessment of eye movements, eyelid position, and visual acuity. Imaging studies, such as o.